SOURCE: Leerink Swann & Co.

May 02, 2005 15:54 ET

Gregory S. Coleman Named Head of Institutional Business for the Investment Banking Firm of Leerink Swann & Company

BOSTON, MA -- (MARKET WIRE) -- May 2, 2005 -- Leerink Swann & Company announced today that Gregory S. Coleman has been named Head of Institutional Business. Mr. Coleman's responsibilities will include oversight for Equity Research, Institutional Sales, Sales Trading and Execution and MEDACorp Research. Mr. Coleman joined Leerink Swann in April 2004 as a Managing Director.

"Greg has been a valuable member of our institutional management team," said Jeffrey A. Leerink, CEO and Chairman of Leerink Swann. "His leadership abilities will help the firm as it continues to deliver industry recognized research and execution services."

Mr. Coleman is a graduate of Drake University. Greg joined Leerink Swann after four years at Credit Suisse First Boston where he was a Senior Relationship Manager. Prior to beginning his career in Institutional equity sales at Sanford C. Bernstein & Co. in 1994, Mr. Coleman held sales and marketing positions at Electronic Data Systems and IBM.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564